Abstract
Fungi from more than 100 genera have been implicated in subcutaneous
fungal infections, usually following traumatic inoculation of the
etiologic agent. With the advent of molecular approaches to fungal
identification and taxonomy, novel agents of subcutaneous mycoses are
increasingly reported. In this manner, Roussoella percutanea, a novel species in Pleosporales,
was described in 2014 from a subcutaneous mass in an immunocompetent
male adult. Two additional cases involving renal transplant recipients
were recently reported from patients resident in France and Germany,
with several further cases discovered after analyses of historical
culture collection isolates. Here, we describe a new case of
subcutaneous R. percutanea
infection, causing a mycotic cyst in a renal transplant patient resident
in the UK. Although fungal infection was confirmed histologically,
viable fungal isolates could not be recovered in culture from biopsy
material and identification of the causative agent relied upon PCR
amplification and sequencing of fungal rDNA genes. This is the fourth
well-documented case of infection with R. percutanea
in renal transplant patients, and the first reported from a patient
resident in the UK. The current case illustrates the importance of
molecular approaches for the identification of emerging fungal pathogens
in culture-negative subcutaneous fungal infections.
Original language | English |
---|---|
Pages (from-to) | 721-725 |
Number of pages | 5 |
Journal | Mycopathologia |
Volume | 182 |
Issue number | 7-8 |
Early online date | 11 Feb 2017 |
DOIs | |
Publication status | Published - Aug 2017 |
Keywords
- Roussoella percutanea
- Emerging pathogen
- rDNA sequencing
- Subcutaneous infection
- Renal transplant
- Pleosporales